PULSE Partner Perspectives
Maryland Daily Record Op-Ed: “Misguided Antitrust Policies Jeopardize Maryland Life Sciences Industry”
In a recent op-ed for The Maryland Daily Record, Kelly Schulz, CEO of PULSE Partner Maryland Tech Council, discusses discusses how federal policy against mergers and acquisitions (M&A) could undermine Maryland’s status as an innovation leader in the life sciences.
NJBIZ Op-Ed: “Federal Anti-M&A Policy Could Undermine New Jersey’s Leadership in the Life Sciences”
In a recent op-ed for NJBIZ, Debbie Hart, President and CEO of PULSE Partner BioNJ, discusses how federal policy against mergers and acquisitions (M&A) could undermine New Jersey’s leadership in the life sciences.
Detroit News Op-Ed: Preserving Michigan’s Competitive Bioscience Industry
In a recent op-ed for the Detroit News, Stephen Rapundalo, President and CEO of PULSE Partner MichBio, highlights the vital role of mergers and acquisitions (M&A) in fueling innovation and competition across Michigan’s life sciences ecosystem.
CBSA: Life Sciences M&A Fuels Growth & Innovation in Colorado
In a recent blog post, PULSE partner Colorado Bioscience Association (CBSA) highlighted the fundamental role of pro-innovation mergers and acquisitions in driving life sciences innovation and economic growth in Colorado and beyond.
What They Are Saying: FTC’s Final HSR Premerger Rules Place Undue Burden on Competitive M&A Across Life Sciences
Leading organizations are expressing concern about the impact of the Federal Trade Commission (FTC)’s final Hart-Scott-Rodino (HSR) premerger notification rule, including the chilling effect it could have on biopharmaceutical and life sciences innovation.
Opinion: New Merger Enforcement Approach Jeopardizes Life Sciences Innovation in NJ
New Jersey has long been home to some of the world’s leading research-based biopharmaceutical companies. Many have made New Jersey a base for their global, North American, or U.S. operations. However, recent policy changes by the Federal Trade Commission and Department of Justice could jeopardize our state’s status as a health care leader.
An Interview with AZBio President and CEO on Life Sciences M&A in Arizona
PULSE sat down for a conversation with Joan Koerber-Walker, president and CEO of AZBio, which recently celebrated 20 years of supporting the growth of Arizona’s life science industry. PULSE asked Joan for her perspective on how mergers and acquisitions (M&A) have impacted and benefited Arizona’s economic outlook and contributions to the state.
Opinion: Proposed regulation would limit life-saving research in Ohio
In a recent op-ed, Ohio Life Sciences President and CEO Eddie Pauline discusses how mergers and acquisitions allow life sciences companies to scale up and provide their research or therapies to patients on a national and global scale.